Authors:
Falcone, A
Allegrini, G
Masi, G
Lencioni, M
Pfanner, E
Brunetti, I
Danesi, R
Bocci, G
Del Tacca, M
Conte, P
Citation: A. Falcone et al., 5-fluorouracil administered as a 48-hour chronomodulated infusion in combination with leucovorin and cisplatin: A randomized phase II study in metastatic colorectal cancer, ONCOL-BASEL, 61(1), 2001, pp. 28-35
Authors:
Gadducci, A
Carnino, F
Chiara, S
Brunetti, I
Tanganelli, L
Romanini, A
Bruzzone, M
Conte, PF
Citation: A. Gadducci et al., Intraperitoneal versus intravenous cisplatin in combination with intravenous cyclophosphamide and epidoxorubicin in optimally cytoreduced advanced epithelial ovarian cancer: A randomized trial of the Gruppo Oncologico Noud-Ovest, GYNECOL ONC, 76(2), 2000, pp. 157-162
Authors:
Falcone, A
Allegrini, G
Lencioni, M
Pfanner, E
Brunetti, I
Cianci, C
Galli, C
Masi, G
Antonuzzo, A
Conte, P
Citation: A. Falcone et al., Protracted continuous infusion of 5-fluorouracil and low-dose leucovorin in patients with metastatic colorectal cancer resistant to 5-fluorouracil bolus-based chemotherapy: a phase II study, CANC CHEMOT, 44(2), 1999, pp. 159-163
Authors:
Bertuccelli, M
Falcone, A
Campoccia, S
Conti, M
Brunetti, I
Caramella, D
Giulianotti, PC
Mosca, F
Bartolozzi, C
Conte, P
Citation: M. Bertuccelli et al., Intrahepatic chemotherapy with floxuridine, leucovorin and dexamethasone in continuous infusion and mitomycin-C bolus in unresectable hepatic metastases from colorectal cancer: A phase II study, TUMORI, 85(6), 1999, pp. 473-477
Authors:
Falcone, A
Allegrini, G
Antonuzzo, A
Brunetti, I
Pfanner, E
Lencioni, M
Masi, G
Danesi, R
Del Tacca, M
Conte, P
Citation: A. Falcone et al., Infusions of fluorouracil and leucovorin: Effects of the timing and semi-intermittency of drug delivery, ONCOL-BASEL, 57(3), 1999, pp. 195-201
Authors:
Falcone, A
Pfanner, E
Brunetti, I
Allegrini, G
Lencioni, M
Galli, C
Masi, G
Danesi, D
Antonuzzo, A
Del Tacca, M
Conte, PF
Citation: A. Falcone et al., Suramin in combination with 5-fluorouracil (5-FU) and leucovorin (LV) in metastatic colorectal cancer patients resistant to 5-FU+LV-based chemotherapy, TUMORI, 84(6), 1998, pp. 666-668